Low molecular weight heparin is associated with better outcomes than unfractionated heparin for thromboprophylaxis in hospitalized COVID-19 patients: a meta-analysis.
Mochamad Yusuf AlsagaffEka Prasetya Budi MuliaIrma MaghfirahYusuf AzmiDita Aulia RachmiAlqi YuthaLuqman Hakim AndiraBambang Pujo SemediPublished in: European heart journal. Quality of care & clinical outcomes (2022)
Our meta-analysis showed that administration of LMWH was associated with better outcomes compared with UFH in hospitalized COVID-19 patients. Prospective cohorts and RCTs are urgently needed to explore the definitive effect of LMWH to provide direct high-certainty evidence. PROSPERO registration number: CRD42021271977.